BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6186631)

  • 1. Vitreous: an inhibitor of retinal extract-induced neovascularization.
    Lutty GA; Thompson DC; Gallup JY; Mello RJ; Patz A; Fenselau A
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):52-6. PubMed ID: 6186631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical mediators of intraocular neovascularization.
    Glaser BM; D'Amore PA; Lutty GA; Fenselau AH; Michels RG; Patz A
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):369-73. PubMed ID: 6171070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic activity of vitreous and retinal extract.
    Chen CH; Chen SC
    Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):596-602. PubMed ID: 6155359
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
    Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of preparations from the vitreous body having anti-angiogenic properties on the metastatic spread of Lewis lung carcinoma].
    Sopotsinskaia EB; Lisniak IA; Balitskiĭ KP
    Eksp Onkol; 1987; 9(2):55-7. PubMed ID: 2438110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.
    Fu Y; Ponce ML; Thill M; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5184-90. PubMed ID: 17962472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in embryonic eye size and retinal cell proliferation following intravitreal injection of glycosaminoglycans.
    Halfter W
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3289-98. PubMed ID: 18362107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The demonstration of angiogenic activity from ocular tissues. Preliminary report.
    Glaser BM; D'Amore PA; Michels RG; Brunson SK; Fenselau AH; Rice T; Patz A
    Ophthalmology; 1980 May; 87(5):440-6. PubMed ID: 6157142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous variation in vitreous fluorophotometry.
    Ross S; Arffa R; Miller D; Weiss JN; Ransil BJ
    Ann Ophthalmol; 1982 Mar; 14(3):245-9. PubMed ID: 7092034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation and characteristics of the neovascularization inhibitor from the vitreous body].
    Lisniak IA
    Vopr Med Khim; 1988; 34(2):16-8. PubMed ID: 3400186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular neovascularization. Tissue culture studies.
    Gu XQ; Fry GL; Lata GF; Packer AJ; Servais EG; Hoak JC; Hayreh SS
    Arch Ophthalmol; 1985 Jan; 103(1):111-7. PubMed ID: 2579627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell growth by vitreous humour.
    Lutty GA; Mello RJ; Chandler C; Fait C; Bennett A; Patz A
    J Cell Sci; 1985 Jun; 76():53-65. PubMed ID: 4066796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial cell effectors in fetal calf retina, vitreous, and serum.
    Chen SC; Chen CH
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):340-50. PubMed ID: 7107160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.
    Chen NT; Corey EJ; Folkman J
    Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenesis factor in intraocular tumors].
    Barraquer RI; Domenech Mateu JM; Fernández Cotero JN; Muiños Muro SJ; Iglesias Touriño E
    Rev Esp Oncol; 1982; 29(3):413-21. PubMed ID: 6084270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances.
    Hazel SJ
    J Lab Clin Med; 2003 Mar; 141(3):217-28. PubMed ID: 12624603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
    Huan-huan C; Li-Li Y; Shang-Bin L
    Cancer Lett; 2004 Aug; 211(2):163-73. PubMed ID: 15219940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine structure and function of ocular tissues. The vitreous.
    Balazs EA
    Int Ophthalmol Clin; 1973; 13(3):169-87. PubMed ID: 4204768
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemistry and biology of the vitreous body.
    Swann DA
    Int Rev Exp Pathol; 1980; 22():1-64. PubMed ID: 7005142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.